Scott Watson Joins Girindus as Vice President, Sales and Marketing

CINCINNATI, Ohio--(BUSINESS WIRE)--August 1, 2008. Girindus, a service provider to the pharmaceutical industry and a leading manufacturer of therapeutic oligonucleotides, announced today that Scott Watson has joined the company to lead its Sales and Marketing efforts. Mr. Watson has over 25 years experience in general management, operations, business development and sales. Prior to joining Girindus he was Senior Director, North American Sales for Aptuit and Director, Business Development for DSM. A 1983 graduate of the U.S. Naval Academy, Mr. Watson served as a submarine officer before entering the pharmaceutical industry in 1991.

"Scott has a demonstrated track record in sales and leadership. We are looking forward to the energy and passion for excellent customer service that he brings to the table”, commented M. Laskovics, PhD, President & COO of Girindus America Inc.

"I am excited about the opportunity to join the Girindus team. Girindus’ technical strengths, combined with the strong financial backing and commitment of Solvay offer a unique and compelling opportunity to support companies developing oligonucleotide medicines." said Watson.

Girindus operates an FDA inspected GMP facility in Cincinnati, Ohio, which is currently undergoing a major expansion, which will double its capacity in oligonucleotide manufacturing.

To learn more, visit Girindus at the Oligonucleotide Therapeutics Society "Fourth Annual Meeting of the Oligonucleotide Therapeutic Society" October 15th-18th, 2008 in Boston.